Diagnostic value of [۹۹mTc]Tc-HYNIC-TOC scintigraphy in the management of differentiated thyroid cancer with elevated thyroglobulin and negative radioiodine whole-body scan

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 185

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IRJNM-30-2_007

تاریخ نمایه سازی: 8 تیر 1401

چکیده مقاله:

Introduction: Negative radioiodine (۱۳۱I) whole-body scan with elevated serum thyroglobulin (Tg) level are found in ۲۰% of patients with differentiated thyroid cancer (DTC), which can be a diagnostic challenge. We evaluated the efficacy of Technetium-۹۹m-Hydrazinonicotinyl-Tyr۳-Octreotide ([۹۹mTc]Tc-HYNIC-TOC) somatostatin receptor scintigraphy (SRS) for detection of non-iodine-avid metastases and its impact on staging and management of these patients. Methods: The study population consisted of ۳۵ DTC patients (۲۵ females; PTC = ۸۸.۲%, FTC = ۱۱.۸%) who had elevated serum Tg levels despite negative post-ablation radioiodine whole-body scan. All patients underwent whole body SRS ۳-۴ hours after intravenous injection of ۲۰mCi (۷۴۰ MBq) of [۹۹mTc]Tc-HYNIC-TOC. Sites of suspected radiotracer accumulation were confirmed with anatomic imaging. Ultimately, corresponding changes in the staging and management were recorded.Results: SRS was positive in ۲۷ (۷۷.۱%) cases. Patients with positive scan had significantly higher Tg levels at the time of scan, compared to those with negative scans (۱۵۴.۵±۱۸۸.۶ vs. ۲۸.۲±۳۲.۷ ng/mL, p-value = ۰.۰۰۵). Interestingly, previous history of neck external beam radiation therapy (EBRT) was significantly correlated with [۹۹mTc]Tc-HYNIC-TOC avidity (Likelihood ratio = ۱۱.۲, p = ۰.۰۰۵). Addition of SSTR scintigraphy changed overall staging and management in ۱۱% and ۳۲.۴% of the patients, respectively.Conclusion: SRS can be a useful diagnostic adjunct in DTC patients with highly elevated Tg and negative radioiodine whole-body scan. The likelihood of positive findings on [۹۹mTc]Tc‑HYNIC‑TOC was higher in cases with previous history of EBRT or high Tg levels (i.e. suppressed-Tg >۸۰ ng/mL) at the time of scan.

نویسندگان

Mohammad Esmatinia

Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Emran Askari

Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Athena Aghaee

Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Parinaz Jahanpanah

Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Narjess Ayati

Department of Nuclear Medicine, Ultrasound and PET, Westmead Hospital, Sydney, Australia

Susan Shafiei

Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Kamran Aryana

Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Fu H, Sa R, Cheng L, Jin Y, Qiu X, ...
  • Asban A, Patel AJ, Reddy S, Wang T, Balentine CJ, ...
  • American Cancer Society. Cancer Facts & Figures ۲۰۲۰. Available at ...
  • Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, ...
  • Schlumberger M, Brose M, Elisei R, Leboulleux S, Luster M, ...
  • Trybek T, Kowalska A, Lesiak J, Młynarczyk J. The role ...
  • Mu ZZ, Zhang X, Lin YS. Identification of Radioactive iodine ...
  • Dionigi G, Fama' F, Pignata SA, Pino A, Pontin A, ...
  • Mourato FA, Almeida MA, Brito AE, Leal AL, Almeida Filho ...
  • Sinha P, Conrad GR, West HC. Response of thyroglobulin to ...
  • Qichang W, Lin B, Gege Z, Youjia Z, Qingjie M, ...
  • Nascimento C, Borget I, Al Ghuzlan A, Deandreis D, Hartl ...
  • Wang H, Dai H, Li Q, Shen G, Shi L, ...
  • Scott A, Boktor R, Lee ST, Berlangieri S. Impact of ...
  • Caetano R, Biz AN, Schluckebier LF, Silva RM, Braga JU, ...
  • Annunziata S, Caldarella C, Treglia G. Cost-effectiveness of Fluorine-۱۸-Fluorodeoxyglucose positron ...
  • Maghsoomi Z, Emami Z, Malboosbaf R, Malek M, Khamseh ME. ...
  • Korde A, Mallia M, Shinto A, Sarma H, Samuel G, ...
  • Jahanpanah P, Shakeri S, Kiamanesh Z, Nasiri Z, Aryana K. ...
  • Hofman MS, Lau WE, Hicks RJ. Somatostatin receptor imaging with ...
  • Görges R, Kahaly G, Müller-Brand J, Mäcke H, Roser HW, ...
  • Valli N, Catargi B, Ronci N, Leccia F, Guyot M, ...
  • Haslinghuis L, Krenning E, De Herder W, Reijs A, Kwekkeboom ...
  • Askari E, Aghaei A, Aryana K. Somatostatin receptor imaging and ...
  • Gabriel M, Froehlich F, Decristoforo C, Ensinger C, Donnemiller E, ...
  • Parisella M, D'Alessandria C, van de Bossche B, Chianelli M, ...
  • Czepczyński R, Kosowicz J, Ziemnicka K, Mikołajczak R, Gryczyńska M, ...
  • Shinto AS, Kamaleshwaran K, Mallia M, Korde A, Samuel G, ...
  • Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid ...
  • Ortega J, Sala C, Flor B, Lledo S. Efficacy and ...
  • Rahbari R, Zhang L, Kebebew E. Thyroid cancer gender disparity. ...
  • Czepczyński R, Gryczyńska M, Ruchała M. [۹۹mTc]Tc-EDDA/HYNIC-TOC in the diagnosis ...
  • Shakeri S, Jahanpanah P, Divband G, Massoudi T, Aryana K. ...
  • Garin E, Devillers A, Le Cloirec J, Bernard A, Lescouarc’h ...
  • Woodmansee WW, Gordon DF, Dowding JM, Stolz B, Lloyd RV, ...
  • Lee DY, Kim YI. Peptide receptor radionuclide therapy in patients ...
  • نمایش کامل مراجع